
Current Presentations
Webcast "Strategic Focusing" as of 25 September 2025 | |
Presentation: Strategic and operational focusing | |
IMS - International Myeloma Society Annual Meeting | |
R&D Webinar June 2025 - Replay: Pioneering New Treatment Options in Relapsed or Refractory Multiple Myeloma with a New Amanitin-based ADC | |
Company presentation September 2025 |
Upcoming Conferences 2025
Event | Date | Location |
---|---|---|
Annual World ADC San Diego 2025
|
3. - 6. November
|
San Diego
|
BIO-Europe
|
3. - 5. November
|
Wien
|
Deutsches Eigenkapitalforum
|
24. - 26. November
|
Frankfurt
|
ASH Annual Meeting
|
6. - 9. Dezember
|
Orlando
|
Past Conferences 2024/2025
Event | Date | Location | Link | Download |
---|---|---|---|---|
BioJapan
|
8. - 10. Oktober
|
Yokohama
| ||
IMS - International Myeloma Society Annual Meeting
|
17. - 20. September
|
Toronto
| ||
ADC & Novel Conjugates Partnering & Investment Summit
|
9. - 10. September
|
Boston
| ||
The Antibody Series 2025
|
9. - 12. September
|
Porto
| ||
ADC Linker & Conjugation Summit
|
19. - 21. August
|
Boston
| ||
ADC Toxicity Summit
|
8. - 10. Juli
|
Boston
| ||
Webinar: Pioneering New Treatment Options in Relapsed or Refractory Multiple Myeloma with a New Amanitin-based ADC
|
17. Juni, 5 pm CEST
| |||
Bio International Convention
|
16. - 19. Juni
|
Boston
| ||
EHA Annual Congress
|
12. - 15. Juni
|
Mailand
| ||
Zacks SCR Life Sciences Investor Forum
|
12. Juni
| |||
World ADC Asia Congress
|
10. - 12. Juni
|
Seoul
| ||
2025 ASCO Annual Meeting
|
30. Mai - 3. Juni
|
Chicago
| ||
Bio €quity Europe 2025
|
12. - 14. Mai
|
Brügge
| Download | |
Frühjahrskonferenz 2025 - Equity Forum
|
12. - 14. Mai
|
Frankfurt
| Download | |
ADC Payload Summit
|
6. - 8. Mai
|
Boston
|
Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.